Literature DB >> 23329365

Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.

Shingo Tanaka1, Koji Miyanishi, Masayoshi Kobune, Yutaka Kawano, Toshifumi Hoki, Tomohiro Kubo, Tsuyoshi Hayashi, Tsutomu Sato, Yasushi Sato, Rishu Takimoto, Junji Kato.   

Abstract

BACKGROUND: The rate of onset of hepatocellular carcinoma (HCC) in patients with nonalcoholic steatohepatitis (NASH) has been reported recently to be comparable to that of patients with chronic hepatitis C. However, the precise mechanism contributing to carcinogenesis in the former remains unclear. Although increased oxidative stress is presumed to play a role in carcinogenesis in patients with NASH, this relationship remains to be directly proven. In this study, we investigated the involvement of oxidative DNA damage in hepatocarcinogenesis in patients with NASH.
METHODS: Patients with nonalcoholic fatty liver disease who were treated at our university hospital were eligible for enrolment in the study(n = 49). The study cohort included 30 patients with NASH without HCC (NASH without HCC), six HCC patients with NASH (NASH-HCC), and 13 patients with simple steatosis. Quantitative immunohistochemistry with a KS-400 image analyzing system was used for 8-hydroxy-2'-deoxyguanosine (8-OHdG) detection.
RESULTS: The 8-OHdG content in the liver tissue of NASH-HCC patients was significantly different from that in the other patients. The median immunostaining intensity was 8.605 in the NASH-HCC cases, which was significantly higher than that in the cases of NASH without HCC (4.845; P = 0.003). Multivariate analysis using hepatic 8-OHdG content as a factor in addition to age and fasting blood sugar revealed a significant difference in clinicopathological factors between NASH-HCC and NASH without HCC cases. Old age (P = 0.015) and high relative immunostaining intensity for intrahepatic 8-OHdG (P = 0.037) were identified as independent factors.
CONCLUSIONS: 8-OHdG content in liver tissue may serve a marker of oxidative stress and could be a particularly useful predictor of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23329365     DOI: 10.1007/s00535-012-0739-0

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  35 in total

1.  Clinicopathological features of non-alcoholic fatty liver disease.

Authors:  Kazushi Sugimoto; Yoshiyuki Takei
Journal:  Hepatol Res       Date:  2011-10       Impact factor: 4.288

2.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Authors:  Mustafa S Ascha; Ibrahim A Hanouneh; Rocio Lopez; Tarek Abu-Rajab Tamimi; Ariel F Feldstein; Nizar N Zein
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

3.  Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma.

Authors:  Masayasu Jo; Taichiro Nishikawa; Tomoki Nakajima; Yoshihisa Okada; Kanji Yamaguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Masaki Iwai; Keizo Kagawa; Yoshito Itoh; Toshikazu Yoshikawa
Journal:  J Gastroenterol       Date:  2011-03-31       Impact factor: 7.527

4.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

Authors:  D K George; S Goldwurm; G A MacDonald; L L Cowley; N I Walker; P J Ward; E C Jazwinska; L W Powell
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis.

Authors:  Katsutoshi Tokushige; Mihoko Takakura; Noriko Tsuchiya-Matsushita; Makiko Taniai; Etsuko Hashimoto; Keiko Shiratori
Journal:  J Hepatol       Date:  2007-02-22       Impact factor: 25.083

8.  8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G----T and A----C substitutions.

Authors:  K C Cheng; D S Cahill; H Kasai; S Nishimura; L A Loeb
Journal:  J Biol Chem       Date:  1992-01-05       Impact factor: 5.157

9.  Expression of 8-hydroxy-2'-deoxyguanosine in chronic liver disease and hepatocellular carcinoma.

Authors:  Miho Ichiba; Yoshiko Maeta; Tomoyuki Mukoyama; Toshiya Saeki; Sakiko Yasui; Takamasa Kanbe; Jun-Ichi Okano; Yoshinao Tanabe; Yasuaki Hirooka; Sadako Yamada; Akihiro Kurimasa; Yoshikazu Murawaki; Goshi Shiota
Journal:  Liver Int       Date:  2003-10       Impact factor: 5.828

10.  Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG.

Authors:  S Shibutani; M Takeshita; A P Grollman
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

View more
  26 in total

1.  Effect of 5-aminolevulinic acid on the expression of carcinogenesis-related proteins in cultured primary hepatocytes.

Authors:  P R Menezes; C B González; A O DeSouza; D A Maria; J Onuki
Journal:  Mol Biol Rep       Date:  2018-09-14       Impact factor: 2.316

Review 2.  DNA damage response and sphingolipid signaling in liver diseases.

Authors:  Masayuki Nagahashi; Yasunobu Matsuda; Kazuki Moro; Junko Tsuchida; Daiki Soma; Yuki Hirose; Takashi Kobayashi; Shin-Ichi Kosugi; Kazuaki Takabe; Masaaki Komatsu; Toshifumi Wakai
Journal:  Surg Today       Date:  2015-10-29       Impact factor: 2.549

3.  Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma.

Authors:  Toshifumi Hoki; Eriko Katsuta; Li Yan; Kazuaki Takabe; Fumito Ito
Journal:  J Surg Res       Date:  2019-02       Impact factor: 2.192

4.  Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and caspase-3 expression in experimental rat model.

Authors:  Mekky M M Abouzied; Heba M Eltahir; Mohamed A Abdel Aziz; Nagwa S Ahmed; Ahmed A Abd El-Ghany; Ebtihal A Abd El-Aziz; Hekmat O Abd El-Aziz
Journal:  Tumour Biol       Date:  2014-12-18

5.  The effect of black raspberry extracts on MnSOD activity in protection against concanavalin A induced liver injury.

Authors:  Xuanyi Li; Yan Li; Vanessa A States; Suping Li; Xiang Zhang; Robert C G Martin
Journal:  Nutr Cancer       Date:  2014-06-09       Impact factor: 2.900

Review 6.  Control of oxidative stress in hepatocellular carcinoma: Helpful or harmful?

Authors:  Akinobu Takaki; Kazuhide Yamamoto
Journal:  World J Hepatol       Date:  2015-05-08

Review 7.  From NASH to HCC: current concepts and future challenges.

Authors:  Quentin M Anstee; Helen L Reeves; Elena Kotsiliti; Olivier Govaere; Mathias Heikenwalder
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-07       Impact factor: 46.802

8.  p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Yuki Hirose; Mami Osawa; Shun Fujimaki; Masayuki Kubota
Journal:  Int J Mol Sci       Date:  2013-11-29       Impact factor: 5.923

Review 9.  The Endless Sources of Hepatocellular Carcinoma Heterogeneity.

Authors:  Marina Barcena-Varela; Amaia Lujambio
Journal:  Cancers (Basel)       Date:  2021-05-26       Impact factor: 6.639

Review 10.  Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC.

Authors:  Yueqi Zhang; Hongbing Wang; Hua Xiao
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.